Search / Trial NCT06235736

Do Patients With ACL Tears Demonstrate Weakness of the Soleus Muscle?

Launched by UNIVERSITY OF LIVERPOOL · Jan 23, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Acute Cruciate Ligament Acl Soleus Muscle Physiotherapy Orthopaedics Trauma Rehabilitation

Description

To address the research question, we will collect and analyse measures of lower limb muscle strength, which together will inform on the strength/ weakness of the Soleus muscle in patients undergoing physiotherapy rehabilitation following MRI-confirmed ACL injury. Patients identified as eligible according to the protocol inclusion and exclusion criteria will be invited to participate in the study through informed written consent so that their clinical measurements can be used as research data. Healthy volunteers will be identified by direct email invitation or word of mouth. Healthy volunte...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ACL tear participants:
  • * MRI-confirmed ACL tear.
  • * Participant is willing and able to give informed consent in writing for participation in the study.
  • * Male or Female, aged 18 years to 55 years of age.
  • * No contraindications to strength testing (see exclusion criteria).
  • Normative values from healthy individuals:
  • * No current or previous history of significant lower limb injury, or a history of previous minor injury that is symptomatic at the time of recruitment.
  • * No previous lower limb surgery.
  • * No course of medication, whether prescribed or over the counter, other than vitamins and mineral supplements or, for females, oral contraceptives.
  • Exclusion Criteria:
  • * History of chronic musculoskeletal disease or disorder in either leg that may put the participants at risk because of participation in the study including non-united fractures, epilepsy, cardiac insufficiency, severe peripheral vascular disease, aneurysms, anticoagulant therapy, recent (\<3 months) radiotherapy or chemotherapy, long term steroid use (\>3 months), pregnancy, neurological disorders (e.g., Parkinson's disease), skin conditions at point of force testing, severe osteoporosis, malignancy, rheumatoid arthritis.
  • * Conditions or symptoms that may influence the result of the study, or the participant's ability to participate in the study including pain, limited range of motion, knee effusion, or anaemia.

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Liverpool, , United Kingdom

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0